ABBV241108C227500
- 0.00
- 0.000.00%
AbbVie Newsroom
AbbVie's (ABBV.US) CD3, CD20 dual-acting antibody acalabrutinib monoclonal antibody has applied for listing in China.
On November 6, the CDE website shows that AbbVie (ABBV.US)'s CD3/CD20 bispecific antibody epcoritamab, with the trade name Epkinly in the USA, has applied for listing in China.
AI Robot Trader Dumped Microsoft, Amazon Stocks and Went Defensive. Here's What It Bought.
Deutsche Bank Adjusts AbbVie Price Target to $180 From $175, Maintains Hold Rating
PureTech: White Most Recently Served as CFO at ImmunoGen Prior to AbbVie Acquisition >PRTC
PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
Seaport Therapeutics Names Lauren White as Chief Financial Officer
Should We Be Delighted With AbbVie Inc.'s (NYSE:ABBV) ROE Of 75%?
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy Right Now?
AbbVie | 10-Q: Q3 2024 Earnings Report
8 High-momentum Stocks Set for Success – Oppenheimer
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
AbbVie Analyst Ratings
Argus Research Upgrades AbbVie(ABBV.US) to Buy Rating
Argus Upgrades AbbVie to Buy From Hold, Price Target Is $220
M&A Deals Roundup: AbbVie, Blackstone, Take-Two Interactive and More
Unusual Options Activity: AMZN, AAPL and Others Attract Market Bets, AMZN V/OI Ratio Reaches 166.7
EST Nov 1st Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Price Over Earnings Overview: AbbVie
AbbVie Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
AbbVie and EvolveImmune Therapeutics Sign Oncology Collaboration